NEWRON PHARMACEUT. EO-20 (NP5) — Cash Flow-to-Debt Ratio
NEWRON PHARMACEUT. EO-20 (NP5) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2025, meaning its operating cash flow of €-1.33 Million could theoretically repay 0% of its total liabilities (€51.15 Million) in one year. Check NEWRON PHARMACEUT. EO-20 total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NEWRON PHARMACEUT. EO-20 Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for NEWRON PHARMACEUT. EO-20 across 21 annual periods. Also explore NEWRON PHARMACEUT. EO-20 assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for NEWRON PHARMACEUT. EO-20 (2005–2025)
Year-by-year debt coverage analysis for NEWRON PHARMACEUT. EO-20. For market capitalisation and broader financial context, see NP5 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | €32.56 Million | €51.15 Million | ▲ +325.7% |
| 2024 | -0.28x | €-17.61 Million | €62.45 Million | ▼ -55.1% |
| 2023 | -0.18x | €-10.14 Million | €55.77 Million | ▲ +16.0% |
| 2022 | -0.22x | €-11.09 Million | €51.23 Million | ▲ +10.4% |
| 2021 | -0.24x | €-11.45 Million | €47.38 Million | ▲ +47.4% |
| 2020 | -0.46x | €-15.59 Million | €33.95 Million | ▲ +50.9% |
| 2019 | -0.94x | €-21.98 Million | €23.49 Million | ▲ +69.7% |
| 2018 | -3.09x | €-15.95 Million | €5.16 Million | ▼ -95.0% |
| 2017 | -1.58x | €-8.40 Million | €5.30 Million | ▲ +44.6% |
| 2016 | -2.86x | €-19.58 Million | €6.84 Million | ▼ -61.7% |
| 2015 | -1.77x | €-12.86 Million | €7.27 Million | ▼ -38.3% |
| 2014 | -1.28x | €-10.00 Million | €7.81 Million | ▼ -26.1% |
| 2013 | -1.02x | €-10.69 Million | €10.53 Million | ▼ -396.9% |
| 2012 | 0.34x | €5.83 Million | €17.04 Million | ▲ +148.3% |
| 2011 | -0.71x | €-4.94 Million | €6.98 Million | ▲ +74.3% |
| 2010 | -2.76x | €-19.13 Million | €6.94 Million | ▼ -48.1% |
| 2009 | -1.86x | €-23.06 Million | €12.39 Million | ▼ -37.5% |
| 2008 | -1.35x | €-19.93 Million | €14.73 Million | ▼ -26.6% |
| 2007 | -1.07x | €-13.87 Million | €12.97 Million | ▼ -103.2% |
| 2006 | -0.53x | €-9.63 Million | €18.30 Million | ▲ +76.2% |
| 2005 | -2.21x | €-14.33 Million | €6.48 Million | — |